Myelodysplastic Syndromes (MDS)

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Read more about Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia

Read more about Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Read more about Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

Read more about Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

Background: Older patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-ti

Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

Read more about Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

Background: Older patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-ti

Raising the bar for lower-risk myelodysplastic syndromes

Read more about Raising the bar for lower-risk myelodysplastic syndromes

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

Read more about Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Newly revised 2023 MDS response criteria

Read more about Newly revised 2023 MDS response criteria

Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care

Read more about Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care

Background: Hematopoietic stem cell transplantation (HCT) is indicated for patients with higher-risk (HR) myelodysplastic syndromes

Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents

Read more about Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents

Purpose of review: To discuss novel targeted therapies under investigation for treatment of myelodysplastic neoplasms (MDS).

Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback